Rapid Dose Therapeutics Corp
CNSX:DOSE
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Rapid Dose Therapeutics Corp
Net Change in Cash
Rapid Dose Therapeutics Corp
Net Change in Cash Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Net Change in Cash | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
R
|
Rapid Dose Therapeutics Corp
CNSX:DOSE
|
Net Change in Cash
-CA$140.3k
|
CAGR 3-Years
-58%
|
CAGR 5-Years
36%
|
CAGR 10-Years
N/A
|
|
|
Covalon Technologies Ltd
XTSX:COV
|
Net Change in Cash
CA$380.5k
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
I
|
Imaging Dynamics Co Ltd
XTSX:IDL
|
Net Change in Cash
-CA$85.3k
|
CAGR 3-Years
-96%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Aurora Spine Corp
XTSX:ASG
|
Net Change in Cash
-$216.3k
|
CAGR 3-Years
58%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
19%
|
|
|
N
|
NuGen Medical Devices Inc
XTSX:NGMD
|
Net Change in Cash
CA$6.5m
|
CAGR 3-Years
64%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
O
|
Ondine Biomedical Inc
LSE:OBI
|
Net Change in Cash
CA$6.8m
|
CAGR 3-Years
-39%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Rapid Dose Therapeutics Corp
Glance View
Rapid Dose Therapeutics Corp. engages in the provision of proprietary drug delivery technologies. The company is headquartered in Burlington, Ontario. The company went IPO on 2018-12-17. The firm provides drug-delivery technologies. The firm also provides production and consultation to the nutraceutical, cannabis healthcare and pharmaceutical manufacturing industries. The company owns an oral fast-dissolving drug delivery system, QuickStrip, which is capable of releasing into the blood stream a list of pharmaceuticals, emulsified oils and over-the-counter medicines without being degraded or modified by first pass metabolism in the liver. Its QuickStrip Energy product delivers energizing caffeine. Its QuickStrip B12 product delivers vitamin B12 to user's system, assisting with metabolism and physical energy. Melatonin is its QuickStrip Sleep product that delivers melatonin to the user's system. The RDMx mixture is its formulation, which is processed using RDT production equipment.
See Also
What is Rapid Dose Therapeutics Corp's Net Change in Cash?
Net Change in Cash
-140.3k
CAD
Based on the financial report for Feb 28, 2025, Rapid Dose Therapeutics Corp's Net Change in Cash amounts to -140.3k CAD.
What is Rapid Dose Therapeutics Corp's Net Change in Cash growth rate?
Net Change in Cash CAGR 5Y
36%
The average annual Net Change in Cash growth rates for Rapid Dose Therapeutics Corp have been -58% over the past three years , 36% over the past five years .
